Caliber Wealth Management LLC KS Reduces Stake in HCA Healthcare, Inc. $HCA

Caliber Wealth Management LLC KS lowered its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 15.8% during the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 6,885 shares of the company’s stock after selling 1,295 shares during the period. Caliber Wealth Management LLC KS’s holdings in HCA Healthcare were worth $2,934,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brighton Jones LLC bought a new stake in HCA Healthcare in the fourth quarter worth $1,021,000. NewEdge Advisors LLC lifted its holdings in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock valued at $1,334,000 after purchasing an additional 409 shares in the last quarter. Sivia Capital Partners LLC raised its position in HCA Healthcare by 5.5% in the 2nd quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after buying an additional 33 shares during the last quarter. Wealthcare Advisory Partners LLC bought a new stake in shares of HCA Healthcare in the second quarter worth approximately $218,000. Finally, US Bancorp DE boosted its holdings in HCA Healthcare by 0.8% in the second quarter. US Bancorp DE now owns 18,864 shares of the company’s stock worth $7,227,000 after purchasing an additional 155 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction dated Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the transaction, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the topic of a number of research reports. Raymond James Financial set a $525.00 price target on HCA Healthcare in a research note on Monday, October 27th. Oppenheimer upped their price target on shares of HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Cantor Fitzgerald increased their price target on shares of HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 28th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Finally, Truist Financial upped their price target on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average target price of $521.55.

HCA Healthcare Price Performance

NYSE HCA opened at $501.89 on Friday. The stock has a market capitalization of $114.53 billion, a PE ratio of 17.68, a P/E/G ratio of 1.54 and a beta of 1.36. The business has a 50 day simple moving average of $479.97 and a two-hundred day simple moving average of $442.72. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $527.55.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period last year, the company posted $6.22 EPS. The business’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.